✦ LIBER ✦

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

✍ Scribed by C.A. Ramos; N. Narala; A.M. Leen; U. Gerdemann; M.L. Anderson; E.M. Sturgis; B. Savoldo; H.E. Heslop; M.K. Brenner; C.M. Rooney

Book ID: 116282886
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.12.049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy with CTL peptide and VSSP

Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors

✍ Isis Torréns; Osmany Mendoza; Aileen Batte; Osvaldo Reyes; Luis E. Fernández; Ci 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Human papillomavirus type 16 E6/E7-speci

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia

✍ Hetty J. Bontkes; Tanja D. de Gruijl; Adrie J.C. van den Muysenberg; René H.M. V 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 102 KB 👁 1 views

Glucocorticoids Stimulate Growth of Huma

Glucocorticoids Stimulate Growth of Human Papillomavirus Type 16 (HPV16)-Immortalized Human Keratinocytes and Support HPV16-Mediated Immortalization without Affecting the Levels of HPV16 E6/E7 mRNA

✍ Mohammad Ali Khan; Alfredo J. Canhoto; Paul R. Housley; Kim E. Creek; Lucia Piri 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Oral immunization with a Lactobacillus c

Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7

✍ Katsuyuki Adachi; Kei Kawana; Terufumi Yokoyama; Tomoyuki Fujii; Ayako Tomio; Sh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Oral immunization with a Lactobacillus c

Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7

✍ Katsuyuki Adachi; Kei Kawana; Terufumi Yokoyama; Tomoyuki Fujii; Ayako Tomio; Sh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Although many clinical trials on human papillomavirus (HPV) therapeutic vaccines have been performed, clinical responses have not been consistent. We have addressed mucosal cytotoxic cellular immune responses to HPV16 E7 after oral immunization of mice with recombinant Lactobacillus casei expressing

A DNA vaccine constructed with human pap

A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses

✍ Qin Yan; Ying-Kit Cheung; Samuel Chak-Sum Cheng; Wang Xian-Hua; Meng Shi; Hu Mei 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 421 KB